Tarek Hamdan

Tarek Hamdan, PharmD, MSc in Biotechnology Management, is a healthcare consultant specializing in market access across Europe and the GCC. He advises pharmaceutical and biotech companies on pricing and reimbursement, HTA and HEOR, early commercialization, and contracting strategies—helping bring innovative therapies into complex healthcare systems.

His experience includes oncology, hematology, vaccines, and other therapeutic areas, where he has collaborated with payers, regulatory authorities, procurement agencies, and key opinion leaders to support access and adoption. He has particular expertise in value-based contracting, tendering strategies, and cross-functional alignment across clinical, commercial, and regulatory functions.

In consulting, Tarek focuses on aligning innovation with healthcare priorities. He is recognized for his ability to navigate diverse market environments and for translating scientific and economic evidence into actionable access strategies. Fluent in English, French, and Arabic, he brings an international and multicultural perspective to healthcare strategy and patient access.